Prolacta Bioscience Enrolls First Infant in Japan-based Clinical Trial to Evaluate the Effect of an Exclusive Human Milk Diet on Growth and Safety in Premature Infants

/PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products for premature and critically ill...

Related Keywords

California ,United States ,Takatsuki ,Osaka ,Japan ,Tokyo ,Saitama ,Gifu ,Loren Kosmont ,Scott Elster ,Katsumi Mizuno ,Prolacta Bioscience ,Prnewswire Prolacta Bioscience ,Instagram ,Linkedin ,Nara Medical University Hospital ,Twitter ,Fujita Health University ,Showa University Hospital ,Showa University Koto Toyosu Hospital ,Showa University Northern Yokohama Hospital ,Showa University School Of Medicine ,Facebook ,Devices Agency ,Exclusive Human Milk Diet ,Controlled Study ,Assess Growth ,Very Low Birth Weight ,Medical Devices ,Showa University School ,Saitama City Hospital ,Tokyo Metropolitan Bokutoh Hospital ,Nagano Children ,Takatsuki General Hospital ,Gifu Prefectural General Medical ,Drug Administration Reviewed ,